<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04738929</url>
  </required_header>
  <id_info>
    <org_study_id>EVCO</org_study_id>
    <nct_id>NCT04738929</nct_id>
  </id_info>
  <brief_title>Comparing EVCO and EVOO</brief_title>
  <official_title>Comparing Acute Effects of Extra Virgin Coconut Oil and Extra Virgin Olive Oil Consumption on Appetite and Food Intake in Normal Weight and Obese Male Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare acute effects of consuming extra virgin coconut oil&#xD;
      (EVCO) as a source of medium chain fatty acids and extra virgin olive oil (EVOO) as a source&#xD;
      of long chain fatty acids in normal weight and obese subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty male subjects (10 normal weight; 10 obese) consumed breakfast meals containing skimmed&#xD;
      milk, fat-free white cheese, bread and EVCO (25 g) or EVOO (25 g). Visual analog scale&#xD;
      evaluations, resting metabolic rate measurements and selected blood parameters analysis&#xD;
      (glucose, triglyceride, insulin and plasma peptide YY) were performed before and after the&#xD;
      test breakfast meals. In addition, energy intakes were evaluated by ad libitum lunch meal at&#xD;
      180 min.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 3, 2019</start_date>
  <completion_date type="Actual">June 3, 2019</completion_date>
  <primary_completion_date type="Actual">June 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy expenditure change</measure>
    <time_frame>0, 60, 120, 180 minutes</time_frame>
    <description>kcal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective appetite feelings change</measure>
    <time_frame>0, 30, 60, 120, 180 minutes</time_frame>
    <description>visual analogue scales rating (0-10 cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose change</measure>
    <time_frame>0, 30, 60, 120, 180 minutes</time_frame>
    <description>mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin change</measure>
    <time_frame>0, 30, 60, 120, 180 minutes</time_frame>
    <description>mU/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>peptide YY change</measure>
    <time_frame>0, 30, 60, 120, 180 minutes</time_frame>
    <description>pg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>triglycerides change</measure>
    <time_frame>0, 30, 60, 120, 180 minutes</time_frame>
    <description>mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ad libitum energy intake</measure>
    <time_frame>180 minute</time_frame>
    <description>kcal</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Obesity</condition>
  <condition>Appetitive Behavior</condition>
  <arm_group>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal weight subjects (BMI=18.5-25)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese subjects (BMI=30-34.99)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Extra virgin coconut oil or extra virgin olive oil</intervention_name>
    <description>Subjects consumed standard breakfast meals containing &quot;extra virgin coconut oil&quot; or &quot;extra virgin olive oil&quot;</description>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_label>Obese</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Metabolically healthy&#xD;
&#xD;
          -  Aged 19-40 years&#xD;
&#xD;
          -  Normal weight (BMI=18.5-24.9 kg/m²) and obese men (BMI=30-34.99 kg/m²)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smoking,&#xD;
&#xD;
          -  alcohol consumption,&#xD;
&#xD;
          -  weight gain/loss recently (&gt; %5, in three months),&#xD;
&#xD;
          -  any genetic and metabolic diseases,&#xD;
&#xD;
          -  any food allergy/intolerance,&#xD;
&#xD;
          -  any medication,&#xD;
&#xD;
          -  restrained eating habits.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only male subjects were included to eliminate potential variations due to hormonal changes during menstrual cycles of female subjects.</gender_description>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziya Erokay Metin, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pelin Bilgiç, Assoc. Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mercan Merve Tengilimoğlu Metin, Assis. Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Muzaffer Akkoca, Assoc. Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Presidency of Republic of Turkey Health Center</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 20, 2021</study_first_submitted>
  <study_first_submitted_qc>February 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara City Hospital Bilkent</investigator_affiliation>
    <investigator_full_name>Ziyaerokaymetin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Extra virgin coconut oil; medium chain fatty acids; extra virgin olive oil; obesity; peptide YY; resting metabolic rate.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

